Ambeed.cn

首页 / 抑制剂/激动剂 / 细胞周期 / DOCK / CPYPP

CPYPP {[allProObj[0].p_purity_real_show]}

货号:A1226465

CPYPP是一种DOCK2抑制剂,以可逆方式结合到DOCK2的DHR-2域,并抑制其体外催化活性。它还抑制DOCK1和DOCK5,并对DOCK9具有选择性。

CPYPP 化学结构 CAS号:310460-39-0
CPYPP 化学结构
CAS号:310460-39-0
CPYPP 3D分子结构
CAS号:310460-39-0
CPYPP 化学结构 CAS号:310460-39-0
CPYPP 3D分子结构 CAS号:310460-39-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

CPYPP 纯度/质量文件 产品仅供科研

货号:A1226465 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

CPYPP 生物活性

描述 DOCK2 is an atypical Rac activator predominantly expressed in hematopoietic cells. CPYPP is a small-molecule inhibitor of DOCK2. It dose-dependently inhibited the nucleotide exchange factor activity of DOCK2DHR-2 for Rac1 with an IC50 value of 22.8±2.4μM. DOCK2 overexpression-induced activation of Rac in HEK293T cells was significantly suppressed by one-hour pretreatment with CPYPP (100μM). Pretreatment of T cells or B cells with CPYPP at a concentration of 100μM for one hour almost completely inhibited Rac activation in response to CCL21 or CXCL13, respectively. One-hour treatment with CPYPP at 100μM inhibited TCR-mediated Rac activation in T cells. Treatment with 100μM CPYPP severely impaired CpG-A-induced Rac activation in pDCs. Intraperitoneal administration of mice with 5mg of CPYPP one hour before adoptive transfer reduced the percentage of migrated T cells to < 25% as compared to the control group[1].
作用机制 CPYPP is a small-molecule inhibitor of DOCK2 that reversibly binds to the DOCK2 DHR-2 domain and inhibited catalytic activity of DOCK2 in vitro[1].

CPYPP 细胞实验

Cell Line
Concentration Treated Time Description References
SAS-DTX 10 µM 24 h Induced cytoplasmic vacuolization and suppressed cell viability Cell Biosci. 2024 Jun 10;14(1):78
OECM1-DTX 10 µM 24 h Induced cytoplasmic vacuolization and suppressed cell viability Cell Biosci. 2024 Jun 10;14(1):78
NCI-H1299 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
PANC-1 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
U-87 MG 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
DBTRG-05MG 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
MDA-MB-435 10 µM 24 h Induced cytoplasmic vacuolization and cell death, inhibited cell proliferation and clonogenic activity Cell Biosci. 2024 Jun 10;14(1):78
MDA-MB-231 10 µM 24 h Induced cytoplasmic vacuolization and cell death, inhibited cell proliferation and clonogenic activity Cell Biosci. 2024 Jun 10;14(1):78
human peripheral blood neutrophils 100 μM 60 min inhibited fMLF-induced Rac2 activation, chemotaxis, and ROS production J Immunol. 2014 Dec 1;193(11):5660-7
RCC7T/E 1–100μM 24 h Measure cell viability, EC50 was 16μM Prostate. 2020 Sep;80(13):1045-1057
VCaP 1–100μM 24 h Measure cell viability, EC50 was 31–35μM Prostate. 2020 Sep;80(13):1045-1057
MDA-PCa2b 1–100μM 24 h Measure cell viability, EC50 was 31–35μM Prostate. 2020 Sep;80(13):1045-1057
CD3+ T cells 100 μM 2 h To evaluate the effect of CPYPP on chemotaxis of CD3+ T cells under CXCL12 stimulation. Results showed that CPYPP significantly inhibited CXCL12-induced chemotaxis (FC=0.57, P=1.0×10−7). Nature. 2022 Sep;609(7928):754-760
pDCs 100 μM 12 h To evaluate the effect of CPYPP on IFNα production by pDCs under CpG stimulation. Results showed that CPYPP significantly reduced IFNα production (FC=5.5×10−5, P=0.0038). Nature. 2022 Sep;609(7928):754-760

CPYPP 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
SCID mice Breast cancer orthotopic xenograft model Intraperitoneal injection 30 mg/kg Daily for 14 days Significantly suppressed tumor growth and induced tumor cell vacuolization Cell Biosci. 2024 Jun 10;14(1):78

CPYPP 参考文献

[1]Nishikimi A, Uruno T, Duan X, Cao Q, Okamura Y, Saitoh T, Saito N, Sakaoka S, Du Y, Suenaga A, Kukimoto-Niino M, Miyano K, Gotoh K, Okabe T, Sanematsu F, Tanaka Y, Sumimoto H, Honma T, Yokoyama S, Nagano T, Kohda D, Kanai M, Fukui Y. Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2. Chem Biol. 2012 Apr 20;19(4):488-97. doi: 10.1016/j.chembiol.2012.03.008

CPYPP 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.40mL

3.08mL

1.54mL

30.79mL

6.16mL

3.08mL

CPYPP 技术信息

CAS号310460-39-0
分子式C18H13ClN2O2
分子量 324.76
SMILES Code O=C(C1=CC=CC2=CC=CC=C2Cl)NN(C3=CC=CC=C3)C1=O
MDL No. MFCD00980987
别名
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 25 mg/mL(76.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。